Should have $58 million cash after the offering excluding any payments from partners. About $40 mill on hand at last quarter end. Every one knew or at least should have known they would at some point be selling shares, unfortunately it was prior to a major deal. Apparently there are no deals on the immediate horizon. Neo and the Osteo Her2 will go forward at no cost. They need partner for hot and combos before starting several trials.
Economy adds more jobs than expected in August, and wage growth hits post-recession high